Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting

Barbara Burtness, Stephen Windsor, Barbara Holston, Susan DiStasio, Carol Staugaard-Hahn, Joan Abrantes, Rayna Kneuper-Hall, Leonard Farber, Jeffrey Orell, Kathleen Bober-Sorcinelli, Bruce G. Haffty, Michael Reiss

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting'. Together they form a unique fingerprint.

Medicine & Life Sciences